(UPDATE) Ixazomib (Ninlaro)
(UPDATE) Daratumumab (MM)
Elotuzumab
Carfilzomib
ASCO: COVID-19 Medical Resources
NCCN Guidelines for Patients: Multiple Myeloma
NCCN-Funded Clinical Trials: Find a Clinical Trial
CancerCare